IDO1/Kyn/AHR axis modulation by Lactobacillus gallinarum-derived ICA enhanced anti-PD1 effectiveness in CRC by inhibiting CD4+Treg differentiation and promoting CD8+T cell activity. The gene discussed is IDO1; the disease is colorectal carcinoma.